Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Induced Parkinson's Disease”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)Study completedNCT01474421
What this trial is testing

Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Who this might be right for
DyskinesiasDrug-induced
Novartis Pharmaceuticals 71
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Not applicableActive Not RecruitingNCT02252380
What this trial is testing

ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders

Who this might be right for
Movement DisordersEssential TremorHolmes Tremor+6 more
InSightec 10
Testing effectiveness (Phase 2)Study completedNCT01173731
What this trial is testing

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedLevodopa
Novartis Pharmaceuticals 66
Large-scale testing (Phase 3)Ended earlyNCT05116813
What this trial is testing

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 17
Testing effectiveness (Phase 2)Study completedNCT01092065
What this trial is testing

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Novartis 23
Early research (Phase 1)Enrolling By InvitationNCT06778265
What this trial is testing

An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease, Idiopathic
Shanghai UniXell Biotechnology Co., Ltd 12
Not applicableStudy completedNCT02409823
What this trial is testing

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar Depressive Disorder+1 more
Pontifical Catholic University of Argentina 665
Not applicableStudy completedNCT04064294
What this trial is testing

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-Induced
VA Office of Research and Development 93
Testing effectiveness (Phase 2)Ended earlyNCT01789047
What this trial is testing

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's DiseaseDrug Induced Dyskinesia
Rush University Medical Center 42
Large-scale testing (Phase 3)Ended earlyNCT04857359
What this trial is testing

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 25
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Not applicableStudy completedNCT02761707
What this trial is testing

Biomarkers in Neural Disorders

Who this might be right for
Parkinson's DiseaseAlzheimer's DiseaseProgressive Supranuclear Palsy+6 more
University of Pennsylvania 54
Not applicableStudy completedNCT00955604
What this trial is testing

Azilect + Antidepressant Chart Review

Who this might be right for
Serotonin Syndrome
Teva Branded Pharmaceutical Products R&D, Inc. 1,500
Not applicableStudy completedNCT00368199
What this trial is testing

Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes

Who this might be right for
Parkinson's DiseaseParkinsonian SyndromeMultiple System Atrophy+4 more
Maastricht University Medical Center 196
Not applicableStudy completedNCT03354455
What this trial is testing

Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 20
Testing effectiveness (Phase 2)Study completedNCT05148884
What this trial is testing

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Who this might be right for
Medication-Induced Dyskinesia
Neurolixis SAS 27
Testing effectiveness (Phase 2)Study completedNCT02657681
What this trial is testing

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

Who this might be right for
Dyskinesia, Medication-InducedParkinson's Disease
Fundación de investigación HM 50
Testing effectiveness (Phase 2)Study completedNCT05297201
What this trial is testing

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-Induced
Celon Pharma SA 105
Testing effectiveness (Phase 2)UnknownNCT04147949
What this trial is testing

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-InducedL-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc. 20
Load More Results